Innovating Works
ERAMET: Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines  UNIVERSITE DE NAMUR ASBL tramitó un HORIZON EUROPE: ERAMET will provide an integrated approach for developers and regulators’ decision-making for paediatric and orphan drugs, centred on the drug development questions. This will constitute a transparent...
2023-11-17 | Financiado
Gravitate-Health: Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment UNIVERSITETET I OSLO tramitó un H2020: The Gravitate-Health mission is to equip and empower citizens with digital information tools that make them confident, active, and responsive in their patient journey, specifically encouraging safe us...
2020-11-01 | Financiado
HARMONY PLUS: HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON tramitó un H2020: Haematological malignancies (HM), also known as blood cancers, are a heterogeneous and complex group of multicausal diseases that can’t be easily diagnosed nor treated. Nowadays most treatments are ex...
2020-10-01 | Financiado
UNICOM: Up-scaling the global univocal identification of medicines EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH tramitó un H2020: This innovation action will give a powerful impulse to implementation of ISO IDMP (ID of Medicinal Products) standards in EU Member States drug databases, supporting safe cross-border ePrescription/eD...
2019-12-01 | Financiado
STARS: Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS) BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE tramitó un H2020: Lack of specific relevant know-how in regulatory science delays the development of new treatment strategies or limits the chances that promising innovations will reach patients. STARS aims to improve...
2019-01-01 | Financiado
HARMONY: Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON tramitó un H2020: Despite significant recent progress in the field of hematological malignancies (HMs), with increasing survival rates and improvement in quality of life, many children and adults with HMs still die fro...
2017-01-01 | Financiado
openMedicine: openMedicine EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH tramitó un H2020: The CSA will enhance the safety of cross-border healthcare through interoperable ePrescriptions. epSOS solved the message transfer problem, but encountered 2 serious delivery problems: the univocal id...
2015-01-01 | Financiado
ADVANCE: Accelerated Development of Vaccine benefit-risk Collaboration in Europe P95 CVBA tramitó un FP6: Aim: The ADVANCE vision is focused on Timely and Best Evidence on Vaccine Effects. Our mission is to establish a best practice framework to rapidly provide robust data on vaccine benefits and risks to...
2013-10-01 | Financiado
SAFEGUARD: Safety Evaluation of Adverse Reactions in Diabetes ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM tramitó un FP7: In 2010 a widely marketed drug for the treatment of type 2 diabetes (T2DM) (rosiglitazone) was taken from the market as it was associated with an increased risk of myocardial infarction, a T2DM compli...
2011-10-01 | Financiado
ECRIN-PPI: European clinical research infrastructures network for clinical trials and biotherapy - preparatory phase for the infrastructure INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un FP7: European clinical research needs an integrated and distributed infrastructure able to provide efficient support to multinational clinical trials, taking advantage of the European population and compet...
2008-03-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.